PRRT2
Proline-rich transmembrane protein 2
Also known as: DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC, PRRT2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z6L0
- Gene
- PRRT2
- Ensembl
- ENSG00000167371
- Chromosome
- 16
- Canonical length
- 340 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
This gene encodes a transmembrane protein containing a proline-rich domain in its N-terminal half. Studies in mice suggest that it is predominantly expressed in brain and spinal cord in embryonic and postnatal stages. Mutations in this gene are associated with episodic kinesigenic dyskinesia-1. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
Canonical amino-acid sequenceUniProt
340 residues, UniProt reviewed canonical sequence.
>Q7Z6L0|PRRT2
1 MAASSSEISE MKGVEESPKV PGEGPGHSEA ETGPPQVLAG VPDQPEAPQP GPNTTAAPVD
61 SGPKAGLAPE TTETPAGASE TAQATDLSLS PGGESKANCS PEDPCQETVS KPEVSKEATA
121 DQGSRLESAA PPEPAPEPAP QPDPRPDSQP TPKPALQPEL PTQEDPTPEI LSESVGEKQE
181 NGAVVPLQAG DGEEGPAPEP HSPPSKKSPP ANGAPPRVLQ QLVEEDRMRR AHSGHPGSPR
241 GSLSRHPSSQ LAGPGVEGGE GTQKPRDYII LAILSCFCPM WPVNIVAFAY AVMSRNSLQQ
301 GDVDGAQRLG RVAKLLSIVA LVGGVLIIIA SCVINLGVYKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRRT2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 305 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 305 nTPM
- cerebral cortex: 128 nTPM
- basal ganglia: 99 nTPM
- ovary: 89 nTPM
- amygdala: 78 nTPM
- hippocampal formation: 61 nTPM
Single-cell type
- ependymal cells: 72 nCPM
- bergmann glia: 64 nCPM
- brain excitatory neurons: 58 nCPM
- astrocytes: 55 nCPM
- brain inhibitory neurons: 41 nCPM
- other brain neurons: 29 nCPM
Immune cell
- NK-cell: 3.3 nTPM
- basophil: 0.4 nTPM
- memory CD4 T-cell: 0.2 nTPM
- eosinophil: 0.1 nTPM
- MAIT T-cell: 0.1 nTPM
- memory CD8 T-cell: 0.1 nTPM
Brain region
- cerebellum: 202 nTPM
- cerebral cortex: 185 nTPM
- basal ganglia: 140 nTPM
- white matter: 123 nTPM
- amygdala: 119 nTPM
- hypothalamus: 117 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PRRT2.
Disease | AllUniProt
Conditions PRRT2 is implicated in, by any mechanism.
- Episodic kinesigenic dyskinesia 1 (EKD1) MIM:128200
- Convulsions, familial infantile, with paroxysmal choreoathetosis (ICCA) MIM:602066
- Seizures, benign familial infantile, 2 (BFIS2) MIM:605751
Disease | GeneticClinVar
159 pathogenic / likely-pathogenic of 736 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Episodic kinesigenic dyskinesia
- Seizures, benign familial infantile, 2
- Episodic kinesigenic dyskinesia 1
- Infantile convulsions and choreoathetosis
- Inborn genetic diseases
Disease | ImmuneIEDB
Conditions an epitope on PRRT2 was assayed in.
- pars planitis B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.58
- gnomAD missense Z
- 0.23
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of SNARE complex assembly
- neuromuscular process controlling posture
- regulation of calcium-dependent activation of synaptic vesicle fusion
- synaptic vesicle fusion to presynaptic active zone membrane
- negative regulation of short-term synaptic potentiation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRRT2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRRT2 as an antibody target. Whether an autoantibody or antibody against PRRT2 could matter depends on whether native PRRT2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRRT2 is annotated at the cell surface, where native PRRT2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PRRT2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...